Development of Sustained Release “NanoFDC (Fixed Dose Combination)” for Hypertension – An Experimental Study

OBJECTIVES: The present study was planned to formulate, characterize and evaluate the pharmacokinetics of a novel “NanoFDC” comprising three commonly prescribed anti-hypertensive drugs, hydrochlorothiazide (a diuretic), candesartan (ARB) and amlodipine (a calcium channel blocker). BASIC METHODS: The...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:PLoS One
Autors principals: Arora, Anjuman, Shafiq, Nusrat, Jain, Sanjay, Khuller, G. K., Sharma, Sadhana, Malhotra, Samir
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2015
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4457799/
https://ncbi.nlm.nih.gov/pubmed/26047011
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0128208
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars